Market Indices
Latest News
 |
| ||
|
Price Targets
from Jefferies issued a price target of $262.00 for ASND on 2026-03-05 21:18:00.The adjusted price target was set to $262.00.At the time of the announcement, ASND was...
March 5, 2026 ASND 0.78%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| DXF Eason Technology Limited | 1.17
26.84% | ||||||||||||||||||
| SLN Silence Therapeutics plc | 6.18
12.36% | ||||||||||||||||||
| IMRN Immuron Limited | 0.87
11.08% | ||||||||||||||||||
| NCNA NuCana plc | 2.16
10.20% | ||||||||||||||||||
| GDS GDS Holdings Limited | 41.75
9.55% | ||||||||||||||||||
| AMBO Ambow Education Holding L | 1.85
9.17% | ||||||||||||||||||
| LEGN Legend Biotech Corporatio | 19.07
7.44% | ||||||||||||||||||
| XTLB XTL Biopharmaceuticals Lt | 0.76
6.94% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 1.34%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA -2.22%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 CUK -4.78%